AU8756698A - Methods for treating skin pigmentation - Google Patents

Methods for treating skin pigmentation Download PDF

Info

Publication number: AU8756698A
Authority: AU; Australia
Prior art keywords: alkyl; compound; amino; par; composition according
Prior art date: 1997-07-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU87566/98A

Other languages

English (en)

Inventor

John Kung

Susan Niemec

Miri Seiberg

Stanley S. Shapiro

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kenvue Brands LLC

Original Assignee

Johnson and Johnson Consumer Companies LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-28

Filing date

1998-07-23

Publication date

1999-02-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27368528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU8756698(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-07-23 Application filed by Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Companies LLC

1999-02-16 Publication of AU8756698A publication Critical patent/AU8756698A/en

Status Abandoned legal-status Critical Current

Links

208000012641 Pigmentation disease Diseases 0.000 title claims description 65
238000000034 method Methods 0.000 title claims description 59
239000000203 mixture Substances 0.000 claims description 180
150000001875 compounds Chemical class 0.000 claims description 164
-1 nitro amino Chemical group 0.000 claims description 136
125000000217 alkyl group Chemical group 0.000 claims description 130
210000003491 skin Anatomy 0.000 claims description 61
235000010469 Glycine max Nutrition 0.000 claims description 59
244000068988 Glycine max Species 0.000 claims description 58
235000013336 milk Nutrition 0.000 claims description 45
239000008267 milk Substances 0.000 claims description 45
210000004080 milk Anatomy 0.000 claims description 45
125000003545 alkoxy group Chemical group 0.000 claims description 44
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 44
125000004356 hydroxy functional group Chemical group O* 0.000 claims description 44
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 38
230000000694 effects Effects 0.000 claims description 37
125000003368 amide group Chemical group 0.000 claims description 36
125000001475 halogen functional group Chemical group 0.000 claims description 36
239000000284 extract Substances 0.000 claims description 34
102000004142 Trypsin Human genes 0.000 claims description 30
108090000631 Trypsin Proteins 0.000 claims description 29
125000003282 alkyl amino group Chemical group 0.000 claims description 27
239000012588 trypsin Substances 0.000 claims description 27
239000003795 chemical substances by application Substances 0.000 claims description 26
239000003001 serine protease inhibitor Substances 0.000 claims description 26
239000002753 trypsin inhibitor Substances 0.000 claims description 26
CNOKQOBEMGIIAH-JYAZKYGWSA-N (2s)-2-[[(2s)-2-[[2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoic acid Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O CNOKQOBEMGIIAH-JYAZKYGWSA-N 0.000 claims description 25
210000002780 melanosome Anatomy 0.000 claims description 25
125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 24
239000003112 inhibitor Substances 0.000 claims description 23
108010014211 seryl-leucyl-isoleucyl-glycyl-arginyl-leucine Proteins 0.000 claims description 23
239000000556 agonist Substances 0.000 claims description 21
244000045232 Canavalia ensiformis Species 0.000 claims description 20
235000010617 Phaseolus lunatus Nutrition 0.000 claims description 20
125000004663 dialkyl amino group Chemical group 0.000 claims description 20
229940122618 Trypsin inhibitor Drugs 0.000 claims description 19
101710162629 Trypsin inhibitor Proteins 0.000 claims description 18
239000002502 liposome Substances 0.000 claims description 18
108090000190 Thrombin Proteins 0.000 claims description 17
102000003425 Tyrosinase Human genes 0.000 claims description 17
108060008724 Tyrosinase Proteins 0.000 claims description 17
229960004072 thrombin Drugs 0.000 claims description 17
235000001014 amino acid Nutrition 0.000 claims description 16
229940024606 amino acid Drugs 0.000 claims description 16
150000001413 amino acids Chemical class 0.000 claims description 16
230000037361 pathway Effects 0.000 claims description 16
241001107116 Castanospermum australe Species 0.000 claims description 15
235000021279 black bean Nutrition 0.000 claims description 15
239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 14
239000003755 preservative agent Substances 0.000 claims description 14
125000001424 substituent group Chemical group 0.000 claims description 13
229940122055 Serine protease inhibitor Drugs 0.000 claims description 12
101710102218 Serine protease inhibitor Proteins 0.000 claims description 12
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 12
239000002253 acid Substances 0.000 claims description 11
239000005557 antagonist Substances 0.000 claims description 11
230000035614 depigmentation Effects 0.000 claims description 11
230000002335 preservative effect Effects 0.000 claims description 11
239000004365 Protease Substances 0.000 claims description 10
239000003963 antioxidant agent Substances 0.000 claims description 10
235000006708 antioxidants Nutrition 0.000 claims description 10
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 10
102000035195 Peptidases Human genes 0.000 claims description 9
108091005804 Peptidases Proteins 0.000 claims description 9
125000004448 alkyl carbonyl group Chemical group 0.000 claims description 9
239000007854 depigmenting agent Substances 0.000 claims description 9
239000003906 humectant Substances 0.000 claims description 9
125000005146 naphthylsulfonyl group Chemical group C1(=CC=CC2=CC=CC=C12)S(=O)(=O)* 0.000 claims description 9
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
238000012546 transfer Methods 0.000 claims description 9
239000003981 vehicle Substances 0.000 claims description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 8
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 8
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 8
102000012479 Serine Proteases Human genes 0.000 claims description 8
108010022999 Serine Proteases Proteins 0.000 claims description 8
108060005989 Tryptase Proteins 0.000 claims description 8
102000001400 Tryptase Human genes 0.000 claims description 8
125000005907 alkyl ester group Chemical group 0.000 claims description 8
108010085544 seryl-leucyl-isoleucyl-glycyl-lysyl-valyl-aspartic acid Proteins 0.000 claims description 8
235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 7
244000046052 Phaseolus vulgaris Species 0.000 claims description 7
125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 7
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 6
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 6
125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 6
235000009582 asparagine Nutrition 0.000 claims description 6
229960001230 asparagine Drugs 0.000 claims description 6
239000002537 cosmetic Substances 0.000 claims description 6
125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 6
125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 6
230000000475 sunscreen effect Effects 0.000 claims description 6
239000000516 sunscreening agent Substances 0.000 claims description 6
239000004094 surface-active agent Substances 0.000 claims description 6
OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 claims description 5
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 5
ZYUZLEUJKZZXNN-UHFFFAOYSA-N C1=CC(CC(N)C(O)=O)=CC=C1OS(=O)(=O)C1=CC=C(C=CC=C2)C2=C1 Chemical group C1=CC(CC(N)C(O)=O)=CC=C1OS(=O)(=O)C1=CC=C(C=CC=C2)C2=C1 ZYUZLEUJKZZXNN-UHFFFAOYSA-N 0.000 claims description 5
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
241000124008 Mammalia Species 0.000 claims description 5
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
235000004279 alanine Nutrition 0.000 claims description 5
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
235000012000 cholesterol Nutrition 0.000 claims description 5
108090000765 processed proteins & peptides Proteins 0.000 claims description 5
239000002750 tryptase inhibitor Substances 0.000 claims description 5
WRQSUCJAKAMYMQ-YFKPBYRVSA-N (2s)-2-(thiophen-3-ylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC=1C=CSC=1 WRQSUCJAKAMYMQ-YFKPBYRVSA-N 0.000 claims description 4
WTOFYLAWDLQMBZ-UHFFFAOYSA-N 2-azaniumyl-3-thiophen-2-ylpropanoate Chemical compound OC(=O)C(N)CC1=CC=CS1 WTOFYLAWDLQMBZ-UHFFFAOYSA-N 0.000 claims description 4
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
239000004471 Glycine Substances 0.000 claims description 4
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 4
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 4
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 4
239000004473 Threonine Substances 0.000 claims description 4
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 4
IADUEWIQBXOCDZ-UHFFFAOYSA-N azetidine-2-carboxylic acid Chemical compound OC(=O)C1CCN1 IADUEWIQBXOCDZ-UHFFFAOYSA-N 0.000 claims description 4
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 4
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
239000007844 bleaching agent Substances 0.000 claims description 4
210000004899 c-terminal region Anatomy 0.000 claims description 4
150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 4
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
235000018417 cysteine Nutrition 0.000 claims description 4
239000003205 fragrance Substances 0.000 claims description 4
235000013922 glutamic acid Nutrition 0.000 claims description 4
239000004220 glutamic acid Substances 0.000 claims description 4
229910052736 halogen Inorganic materials 0.000 claims description 4
150000002367 halogens Chemical class 0.000 claims description 4
125000000623 heterocyclic group Chemical group 0.000 claims description 4
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
229960000310 isoleucine Drugs 0.000 claims description 4
HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 claims description 4
229930182817 methionine Natural products 0.000 claims description 4
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
229910052757 nitrogen Inorganic materials 0.000 claims description 4
150000002993 phenylalanine derivatives Chemical class 0.000 claims description 4
HXEACLLIILLPRG-UHFFFAOYSA-N pipecolic acid Chemical compound OC(=O)C1CCCCN1 HXEACLLIILLPRG-UHFFFAOYSA-N 0.000 claims description 4
NPDBDJFLKKQMCM-UHFFFAOYSA-N tert-butylglycine Chemical compound CC(C)(C)C(N)C(O)=O NPDBDJFLKKQMCM-UHFFFAOYSA-N 0.000 claims description 4
239000004474 valine Substances 0.000 claims description 4
241000219104 Cucurbitaceae Species 0.000 claims description 3
241000220485 Fabaceae Species 0.000 claims description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
241000209504 Poaceae Species 0.000 claims description 3
241000208292 Solanaceae Species 0.000 claims description 3
235000003704 aspartic acid Nutrition 0.000 claims description 3
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
229910052799 carbon Inorganic materials 0.000 claims description 3
239000003995 emulsifying agent Substances 0.000 claims description 3
235000021374 legumes Nutrition 0.000 claims description 3
229930014626 natural product Natural products 0.000 claims description 3
102000004196 processed proteins & peptides Human genes 0.000 claims description 3
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
YPJJGMCMOHDOFZ-ZETCQYMHSA-N (2s)-2-(1-benzothiophen-3-ylamino)propanoic acid Chemical compound C1=CC=C2C(N[C@@H](C)C(O)=O)=CSC2=C1 YPJJGMCMOHDOFZ-ZETCQYMHSA-N 0.000 claims description 2
IYKLZBIWFXPUCS-VIFPVBQESA-N (2s)-2-(naphthalen-1-ylamino)propanoic acid Chemical compound C1=CC=C2C(N[C@@H](C)C(O)=O)=CC=CC2=C1 IYKLZBIWFXPUCS-VIFPVBQESA-N 0.000 claims description 2
CNMAQBJBWQQZFZ-LURJTMIESA-N (2s)-2-(pyridin-2-ylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC1=CC=CC=N1 CNMAQBJBWQQZFZ-LURJTMIESA-N 0.000 claims description 2
WTKYBFQVZPCGAO-LURJTMIESA-N (2s)-2-(pyridin-3-ylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC1=CC=CN=C1 WTKYBFQVZPCGAO-LURJTMIESA-N 0.000 claims description 2
WAMWSIDTKSNDCU-ZETCQYMHSA-N (2s)-2-azaniumyl-2-cyclohexylacetate Chemical compound OC(=O)[C@@H](N)C1CCCCC1 WAMWSIDTKSNDCU-ZETCQYMHSA-N 0.000 claims description 2
125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 2
OXFGRWIKQDSSLY-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinolin-2-ium-1-carboxylate Chemical compound C1=CC=C2C(C(=O)O)NCCC2=C1 OXFGRWIKQDSSLY-UHFFFAOYSA-N 0.000 claims description 2
XFZIPCXDWCWTCH-UHFFFAOYSA-N 1,3-oxazolidin-3-ium-4-carboxylate Chemical compound OC(=O)C1COCN1 XFZIPCXDWCWTCH-UHFFFAOYSA-N 0.000 claims description 2
OCQICQZUUHJWGZ-UHFFFAOYSA-N 2,2-Dimethylthiazolidine-4-Carboxylic Acid Chemical compound CC1(C)NC(C(O)=O)CS1 OCQICQZUUHJWGZ-UHFFFAOYSA-N 0.000 claims description 2
KFLKTDAONDZLAN-UHFFFAOYSA-N 2-(n-phenylanilino)acetic acid Chemical compound C=1C=CC=CC=1N(CC(=O)O)C1=CC=CC=C1 KFLKTDAONDZLAN-UHFFFAOYSA-N 0.000 claims description 2
JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 claims description 2
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
YXDGRBPZVQPESQ-QMMMGPOBSA-N 4-[(2s)-2-amino-2-carboxyethyl]benzoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(C(O)=O)C=C1 YXDGRBPZVQPESQ-QMMMGPOBSA-N 0.000 claims description 2
PMQQFSDIECYOQV-UHFFFAOYSA-N 5,5-dimethyl-1,3-thiazolidin-3-ium-4-carboxylate Chemical compound CC1(C)SCNC1C(O)=O PMQQFSDIECYOQV-UHFFFAOYSA-N 0.000 claims description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 2
ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 claims description 2
JTTHKOPSMAVJFE-VIFPVBQESA-N L-homophenylalanine Chemical compound OC(=O)[C@@H](N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-VIFPVBQESA-N 0.000 claims description 2
QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical compound C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 claims description 2
UCUNFLYVYCGDHP-BYPYZUCNSA-N L-methionine sulfone Chemical compound CS(=O)(=O)CC[C@H](N)C(O)=O UCUNFLYVYCGDHP-BYPYZUCNSA-N 0.000 claims description 2
QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Natural products CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 claims description 2
LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 claims description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
239000004909 Moisturizer Substances 0.000 claims description 2
206010040829 Skin discolouration Diseases 0.000 claims description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 2
150000003862 amino acid derivatives Chemical class 0.000 claims description 2
JCZLABDVDPYLRZ-AWEZNQCLSA-N biphenylalanine Chemical compound C1=CC(C[C@H](N)C(O)=O)=CC=C1C1=CC=CC=C1 JCZLABDVDPYLRZ-AWEZNQCLSA-N 0.000 claims description 2
239000006172 buffering agent Substances 0.000 claims description 2
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 2
150000002148 esters Chemical class 0.000 claims description 2
239000004088 foaming agent Substances 0.000 claims description 2
125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 claims description 2
239000001257 hydrogen Substances 0.000 claims description 2
229910052739 hydrogen Inorganic materials 0.000 claims description 2
229960002591 hydroxyproline Drugs 0.000 claims description 2
125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 claims description 2
125000004254 isoquinolin-1-yl group Chemical group [H]C1=C([H])C2=C([H])C([H])=C([H])C([H])=C2C(*)=N1 0.000 claims description 2
125000004551 isoquinolin-3-yl group Chemical group C1=NC(=CC2=CC=CC=C12)* 0.000 claims description 2
125000001793 isothiazol-3-yl group Chemical group [H]C1=C([H])C(*)=NS1 0.000 claims description 2
125000004501 isothiazol-5-yl group Chemical group S1N=CC=C1* 0.000 claims description 2
230000001333 moisturizer Effects 0.000 claims description 2
CQYBNXGHMBNGCG-RNJXMRFFSA-N octahydroindole-2-carboxylic acid Chemical compound C1CCC[C@H]2N[C@H](C(=O)O)C[C@@H]21 CQYBNXGHMBNGCG-RNJXMRFFSA-N 0.000 claims description 2
125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 claims description 2
229920001184 polypeptide Polymers 0.000 claims description 2
125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims description 2
125000004260 quinazolin-2-yl group Chemical group [H]C1=NC(*)=NC2=C1C([H])=C([H])C([H])=C2[H] 0.000 claims description 2
150000003839 salts Chemical class 0.000 claims description 2
125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims description 2
125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 claims description 2
125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 claims description 2
125000004301 thiazolin-2-yl group Chemical group [H]C1([H])SC(*)=NC1([H])[H] 0.000 claims description 2
DZLNHFMRPBPULJ-UHFFFAOYSA-N thioproline Chemical compound OC(=O)C1CSCN1 DZLNHFMRPBPULJ-UHFFFAOYSA-N 0.000 claims description 2
JPZXHKDZASGCLU-LBPRGKRZSA-N β-(2-naphthyl)-alanine Chemical compound C1=CC=CC2=CC(C[C@H](N)C(O)=O)=CC=C21 JPZXHKDZASGCLU-LBPRGKRZSA-N 0.000 claims description 2
NTQVODZUQIATFS-WAUHAFJUSA-N (2s)-2-[[(2s)-6-amino-2-[[2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-methylbutanoic acid Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O NTQVODZUQIATFS-WAUHAFJUSA-N 0.000 claims 30
102100037132 Proteinase-activated receptor 2 Human genes 0.000 claims 30
101710121435 Proteinase-activated receptor 2 Proteins 0.000 claims 30
235000020712 soy bean extract Nutrition 0.000 claims 6
CRRVWYVHDQNJGU-WNYONQOASA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;(2r)-2-amino-3-phenylpropanoic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical group OC(=O)[C@@H]1CCCN1.OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@H](N)CC1=CC=CC=C1 CRRVWYVHDQNJGU-WNYONQOASA-N 0.000 claims 2
239000003623 enhancer Substances 0.000 claims 2
125000004400 (C1-C12) alkyl group Chemical group 0.000 claims 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 claims 1
229940122598 Tryptase inhibitor Drugs 0.000 claims 1
125000005138 alkoxysulfonyl group Chemical group 0.000 claims 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
108010070503 PAR-2 Receptor Proteins 0.000 description 70
102000018402 Protease-activated receptor 2 Human genes 0.000 description 70
238000009472 formulation Methods 0.000 description 58
230000019612 pigmentation Effects 0.000 description 56
210000002752 melanocyte Anatomy 0.000 description 55
238000011282 treatment Methods 0.000 description 41
210000002510 keratinocyte Anatomy 0.000 description 29
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
230000002087 whitening effect Effects 0.000 description 23
241000282414 Homo sapiens Species 0.000 description 21
230000014509 gene expression Effects 0.000 description 21
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
239000004615 ingredient Substances 0.000 description 16
241000282898 Sus scrofa Species 0.000 description 15
230000003061 melanogenesis Effects 0.000 description 15
108090000623 proteins and genes Proteins 0.000 description 14
102000005962 receptors Human genes 0.000 description 13
108020003175 receptors Proteins 0.000 description 13
239000003868 thrombin inhibitor Substances 0.000 description 13
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
239000000047 product Substances 0.000 description 12
QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 11
229940122388 Thrombin inhibitor Drugs 0.000 description 11
230000002829 reductive effect Effects 0.000 description 11
XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 10
102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 9
101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 9
102100031413 L-dopachrome tautomerase Human genes 0.000 description 9
101710093778 L-dopachrome tautomerase Proteins 0.000 description 9
101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 9
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 9
239000003974 emollient agent Substances 0.000 description 9
239000000499 gel Substances 0.000 description 9
239000000463 material Substances 0.000 description 9
LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 8
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 8
HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 8
239000008367 deionised water Substances 0.000 description 8
239000013615 primer Substances 0.000 description 8
230000001225 therapeutic effect Effects 0.000 description 8
101000712605 Theromyzon tessulatum Theromin Proteins 0.000 description 7
239000004480 active ingredient Substances 0.000 description 7
230000000692 anti-sense effect Effects 0.000 description 7
229910021641 deionized water Inorganic materials 0.000 description 7
239000002562 thickening agent Substances 0.000 description 7
BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 6
230000004913 activation Effects 0.000 description 6
230000003078 antioxidant effect Effects 0.000 description 6
231100000673 dose–response relationship Toxicity 0.000 description 6
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 6
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
239000003921 oil Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
238000010186 staining Methods 0.000 description 6
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 5
229940122985 Peptide agonist Drugs 0.000 description 5
239000013543 active substance Substances 0.000 description 5
230000008859 change Effects 0.000 description 5
239000002738 chelating agent Substances 0.000 description 5
MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
229960004502 levodopa Drugs 0.000 description 5
108020004999 messenger RNA Proteins 0.000 description 5
238000002156 mixing Methods 0.000 description 5
239000007764 o/w emulsion Substances 0.000 description 5
239000012071 phase Substances 0.000 description 5
235000019419 proteases Nutrition 0.000 description 5
235000018102 proteins Nutrition 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
239000002904 solvent Substances 0.000 description 5
230000007480 spreading Effects 0.000 description 5
238000003892 spreading Methods 0.000 description 5
238000012360 testing method Methods 0.000 description 5
HAGOWCONESKMDW-FRSCJGFNSA-N (2s)-4-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-oxobutanoic acid Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CC=CC=C1 HAGOWCONESKMDW-FRSCJGFNSA-N 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
229940118430 Protease-activated receptor-2 antagonist Drugs 0.000 description 4
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
108010073771 Soybean Proteins Proteins 0.000 description 4
239000012190 activator Substances 0.000 description 4
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
239000008346 aqueous phase Substances 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
230000000481 effect on pigmentation Effects 0.000 description 4
238000001493 electron microscopy Methods 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
210000002615 epidermis Anatomy 0.000 description 4
235000011187 glycerol Nutrition 0.000 description 4
238000010191 image analysis Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
230000003993 interaction Effects 0.000 description 4
238000005259 measurement Methods 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 4
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
230000001603 reducing effect Effects 0.000 description 4
238000003757 reverse transcription PCR Methods 0.000 description 4
230000002441 reversible effect Effects 0.000 description 4
239000000523 sample Substances 0.000 description 4
229910052709 silver Inorganic materials 0.000 description 4
239000004332 silver Substances 0.000 description 4
238000003756 stirring Methods 0.000 description 4
108010063955 thrombin receptor peptide (42-47) Proteins 0.000 description 4
229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 3
ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
102000016911 Deoxyribonucleases Human genes 0.000 description 3
108010053770 Deoxyribonucleases Proteins 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
102000007625 Hirudins Human genes 0.000 description 3
108010007267 Hirudins Proteins 0.000 description 3
244000294411 Mirabilis expansa Species 0.000 description 3
235000015429 Mirabilis expansa Nutrition 0.000 description 3
229920002125 Sokalan® Polymers 0.000 description 3
150000001252 acrylic acid derivatives Chemical class 0.000 description 3
238000001574 biopsy Methods 0.000 description 3
238000003501 co-culture Methods 0.000 description 3
229920006037 cross link polymer Polymers 0.000 description 3
ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
210000001787 dendrite Anatomy 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
238000009826 distribution Methods 0.000 description 3
229940006607 hirudin Drugs 0.000 description 3
WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
230000007794 irritation Effects 0.000 description 3
KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 3
239000007788 liquid Substances 0.000 description 3
230000003101 melanogenic effect Effects 0.000 description 3
201000001441 melanoma Diseases 0.000 description 3
235000013536 miso Nutrition 0.000 description 3
210000002445 nipple Anatomy 0.000 description 3
239000013641 positive control Substances 0.000 description 3
230000008569 process Effects 0.000 description 3
229910001961 silver nitrate Inorganic materials 0.000 description 3
239000011734 sodium Substances 0.000 description 3
235000013322 soy milk Nutrition 0.000 description 3
239000000126 substance Substances 0.000 description 3
229940042585 tocopherol acetate Drugs 0.000 description 3
230000000699 topical effect Effects 0.000 description 3
229940088594 vitamin Drugs 0.000 description 3
239000011782 vitamin Substances 0.000 description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
HNUQMTZUNUBOLQ-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO HNUQMTZUNUBOLQ-UHFFFAOYSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
241000700198 Cavia Species 0.000 description 2
240000001980 Cucurbita pepo Species 0.000 description 2
235000009852 Cucurbita pepo Nutrition 0.000 description 2
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
108020001019 DNA Primers Proteins 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
102000014944 Lysosome-Associated Membrane Glycoproteins Human genes 0.000 description 2
108010064171 Lysosome-Associated Membrane Glycoproteins Proteins 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
101100406879 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) par-2 gene Proteins 0.000 description 2
102000003923 Protein Kinase C Human genes 0.000 description 2
108090000315 Protein Kinase C Proteins 0.000 description 2
102100037136 Proteinase-activated receptor 1 Human genes 0.000 description 2
101710121440 Proteinase-activated receptor 1 Proteins 0.000 description 2
239000013614 RNA sample Substances 0.000 description 2
102000003790 Thrombin receptors Human genes 0.000 description 2
108090000166 Thrombin receptors Proteins 0.000 description 2
229930003427 Vitamin E Natural products 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
125000005250 alkyl acrylate group Chemical group 0.000 description 2
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
210000001142 back Anatomy 0.000 description 2
229960001631 carbomer Drugs 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
229940086555 cyclomethicone Drugs 0.000 description 2
RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
239000012634 fragment Substances 0.000 description 2
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
230000012010 growth Effects 0.000 description 2
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
239000000413 hydrolysate Substances 0.000 description 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
235000010446 mineral oil Nutrition 0.000 description 2
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
229940101267 panthenol Drugs 0.000 description 2
235000020957 pantothenol Nutrition 0.000 description 2
239000011619 pantothenol Substances 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
239000000049 pigment Substances 0.000 description 2
229940068196 placebo Drugs 0.000 description 2
239000000902 placebo Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
229960003471 retinol Drugs 0.000 description 2
235000020944 retinol Nutrition 0.000 description 2
239000011607 retinol Substances 0.000 description 2
230000007017 scission Effects 0.000 description 2
230000011664 signaling Effects 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
229940001941 soy protein Drugs 0.000 description 2
235000019710 soybean protein Nutrition 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
229960001727 tretinoin Drugs 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
238000012800 visualization Methods 0.000 description 2
229940046009 vitamin E Drugs 0.000 description 2
235000019165 vitamin E Nutrition 0.000 description 2
239000011709 vitamin E Substances 0.000 description 2
239000007762 w/o emulsion Substances 0.000 description 2
GAUUPDQWKHTCAX-VIFPVBQESA-N (2s)-2-amino-3-(1-benzothiophen-3-yl)propanoic acid Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CSC2=C1 GAUUPDQWKHTCAX-VIFPVBQESA-N 0.000 description 1
CRRVWYVHDQNJGU-ZVIMSEFHSA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;(2s)-2-amino-3-phenylpropanoic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical group OC(=O)[C@@H]1CCCN1.OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@@H](N)CC1=CC=CC=C1 CRRVWYVHDQNJGU-ZVIMSEFHSA-N 0.000 description 1
SGPMJRPYYIJZPC-JYAZKYGWSA-N (2s,3s)-2-[[(2s)-2-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-n-[2-[[(2s)-1-[[(2s)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-3-methylpentanamide Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(N)=O SGPMJRPYYIJZPC-JYAZKYGWSA-N 0.000 description 1
150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
BPZYKPINOMFZGY-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)c1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1 BPZYKPINOMFZGY-UHFFFAOYSA-N 0.000 description 1
QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
YFTGOBNOJKXZJC-UHFFFAOYSA-N 5,6-dihydroxyindole-2-carboxylic acid Chemical compound OC1=C(O)C=C2NC(C(=O)O)=CC2=C1 YFTGOBNOJKXZJC-UHFFFAOYSA-N 0.000 description 1
238000012232 AGPC extraction Methods 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
206010001557 Albinism Diseases 0.000 description 1
108010039627 Aprotinin Proteins 0.000 description 1
244000105624 Arachis hypogaea Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
208000002109 Argyria Diseases 0.000 description 1
235000007319 Avena orientalis Nutrition 0.000 description 1
244000075850 Avena orientalis Species 0.000 description 1
HHFUPQYJUZKHSG-UHFFFAOYSA-N C(CC)OC(=O)C1=CC=C(O)C=C1.COC(C(=O)O)=CC1=CC=CC=C1 Chemical compound C(CC)OC(=O)C1=CC=C(O)C=C1.COC(C(=O)O)=CC1=CC=CC=C1 HHFUPQYJUZKHSG-UHFFFAOYSA-N 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
240000008067 Cucumis sativus Species 0.000 description 1
235000009849 Cucumis sativus Nutrition 0.000 description 1
235000009854 Cucurbita moschata Nutrition 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
101100438426 Drosophila melanogaster Art4 gene Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
206010014970 Ephelides Diseases 0.000 description 1
231100000948 EpiDerm Skin Irritation Test Toxicity 0.000 description 1
240000008620 Fagopyrum esculentum Species 0.000 description 1
235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
240000005979 Hordeum vulgare Species 0.000 description 1
235000007340 Hordeum vulgare Nutrition 0.000 description 1
SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
208000021710 Hyperpigmentation disease Diseases 0.000 description 1
208000026748 Hypopigmentation disease Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
240000004322 Lens culinaris Species 0.000 description 1
235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
235000003956 Luffa Nutrition 0.000 description 1
244000050983 Luffa operculata Species 0.000 description 1
235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
208000003351 Melanosis Diseases 0.000 description 1
101001098561 Mus musculus Proteinase-activated receptor 2 Proteins 0.000 description 1
MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
101710186509 Partitioning defective 3 homolog Proteins 0.000 description 1
240000004713 Pisum sativum Species 0.000 description 1
235000010582 Pisum sativum Nutrition 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
102000002020 Protease-activated receptors Human genes 0.000 description 1
108050009310 Protease-activated receptors Proteins 0.000 description 1
108010009736 Protein Hydrolysates Proteins 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
102100037133 Proteinase-activated receptor 3 Human genes 0.000 description 1
101710121425 Proteinase-activated receptor 3 Proteins 0.000 description 1
238000002123 RNA extraction Methods 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
206010040825 Skin depigmentation Diseases 0.000 description 1
240000003768 Solanum lycopersicum Species 0.000 description 1
244000061456 Solanum tuberosum Species 0.000 description 1
235000002595 Solanum tuberosum Nutrition 0.000 description 1
240000006394 Sorghum bicolor Species 0.000 description 1
235000011684 Sorghum saccharatum Nutrition 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
108090001109 Thermolysin Proteins 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
244000098338 Triticum aestivum Species 0.000 description 1
101710112930 Trypsin inhibitor 1 Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000032683 aging Effects 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000012863 analytical testing Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
229960004405 aprotinin Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000008901 benefit Effects 0.000 description 1
125000005605 benzo group Chemical group 0.000 description 1
229960004217 benzyl alcohol Drugs 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
229940071160 cocoate Drugs 0.000 description 1
239000002131 composite material Substances 0.000 description 1
229940125773 compound 10 Drugs 0.000 description 1
229940125898 compound 5 Drugs 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
210000005220 cytoplasmic tail Anatomy 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
230000001687 destabilization Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
229940120503 dihydroxyacetone Drugs 0.000 description 1
229940008099 dimethicone Drugs 0.000 description 1
239000004205 dimethyl polysiloxane Substances 0.000 description 1
235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
210000005175 epidermal keratinocyte Anatomy 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
230000008713 feedback mechanism Effects 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
239000003349 gelling agent Substances 0.000 description 1
229930182478 glucoside Natural products 0.000 description 1
150000008131 glucosides Chemical class 0.000 description 1
238000000227 grinding Methods 0.000 description 1
238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
UXALQTVODWAKFT-UHFFFAOYSA-N heptan-2-one;hydrochloride Chemical compound Cl.CCCCCC(C)=O UXALQTVODWAKFT-UHFFFAOYSA-N 0.000 description 1
238000010562 histological examination Methods 0.000 description 1
239000010903 husk Substances 0.000 description 1
229940072106 hydroxystearate Drugs 0.000 description 1
208000000069 hyperpigmentation Diseases 0.000 description 1
230000003810 hyperpigmentation Effects 0.000 description 1
230000003425 hypopigmentation Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
229960004705 kojic acid Drugs 0.000 description 1
229940031674 laureth-7 Drugs 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
108010052968 leupeptin Proteins 0.000 description 1
239000003446 ligand Substances 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
230000008099 melanin synthesis Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
229960002216 methylparaben Drugs 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
YFCUZWYIPBUQBD-ZOWNYOTGSA-N n-[(3s)-7-amino-1-chloro-2-oxoheptan-3-yl]-4-methylbenzenesulfonamide;hydron;chloride Chemical compound Cl.CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)C=C1 YFCUZWYIPBUQBD-ZOWNYOTGSA-N 0.000 description 1
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
239000013642 negative control Substances 0.000 description 1
210000000933 neural crest Anatomy 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
229920004908 octoxynol-13 Polymers 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
235000020232 peanut Nutrition 0.000 description 1
230000035515 penetration Effects 0.000 description 1
125000001151 peptidyl group Chemical group 0.000 description 1
229960005323 phenoxyethanol Drugs 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000008832 photodamage Effects 0.000 description 1
230000000485 pigmenting effect Effects 0.000 description 1
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
CMDGQTVYVAKDNA-UHFFFAOYSA-N propane-1,2,3-triol;hydrate Chemical compound O.OCC(O)CO CMDGQTVYVAKDNA-UHFFFAOYSA-N 0.000 description 1
239000008213 purified water Substances 0.000 description 1
230000005855 radiation Effects 0.000 description 1
102000027483 retinoid hormone receptors Human genes 0.000 description 1
108091008679 retinoid hormone receptors Proteins 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
210000004739 secretory vesicle Anatomy 0.000 description 1
239000000243 solution Substances 0.000 description 1
241000894007 species Species 0.000 description 1
235000020354 squash Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
230000008685 targeting Effects 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
238000010246 ultrastructural analysis Methods 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
230000035899 viability Effects 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Mycology (AREA)
Botany (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Toxicology (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU87566/98A 1997-07-28 1998-07-23 Methods for treating skin pigmentation Abandoned AU8756698A (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US5394297P	1997-07-28	1997-07-28
US60053942		1997-07-28
US8044198P	1998-04-02	1998-04-02
US60080441		1998-04-02
US09/110,409 US8039026B1 (en)	1997-07-28	1998-07-06	Methods for treating skin pigmentation
US09110409		1998-07-06
PCT/US1998/009799 WO1999004752A2 (fr)	1997-07-28	1998-07-23	Procede pour le traitement de la pigmentation de la peau

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002313834A Division AU2002313834A1 (en)	1997-07-28	2002-12-05	Methods for treating skin pigmentation

Publications (1)

Publication Number	Publication Date
AU8756698A true AU8756698A (en)	1999-02-16

Family

ID=27368528

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU87566/98A Abandoned AU8756698A (en)	1997-07-28	1998-07-23	Methods for treating skin pigmentation

Country Status (20)

Country	Link
US (3)	US8039026B1 (fr)
EP (1)	EP0948308B1 (fr)
JP (2)	JP4401441B2 (fr)
KR (1)	KR100691395B1 (fr)
CN (1)	CN1234735B (fr)
AR (1)	AR016780A1 (fr)
AT (1)	ATE260083T1 (fr)
AU (1)	AU8756698A (fr)
BR (2)	BR9806118A (fr)
CA (1)	CA2267077C (fr)
DE (1)	DE69821913T2 (fr)
DK (1)	DK0948308T3 (fr)
ES (1)	ES2215317T3 (fr)
HU (1)	HUP0000216A3 (fr)
ID (1)	ID22061A (fr)
IL (1)	IL129090A0 (fr)
PL (1)	PL333284A1 (fr)
PT (1)	PT948308E (fr)
TW (1)	TW557216B (fr)
WO (1)	WO1999004752A2 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6346510B1 (en)	1995-10-23	2002-02-12	The Children's Medical Center Corporation	Therapeutic antiangiogenic endostatin compositions
US8039026B1 (en)	1997-07-28	2011-10-18	Johnson & Johnson Consumer Companies, Inc	Methods for treating skin pigmentation
US6750229B2 (en)	1998-07-06	2004-06-15	Johnson & Johnson Consumer Companies, Inc.	Methods for treating skin pigmentation
US8106094B2 (en)	1998-07-06	2012-01-31	Johnson & Johnson Consumer Companies, Inc.	Compositions and methods for treating skin conditions
US8093293B2 (en)	1998-07-06	2012-01-10	Johnson & Johnson Consumer Companies, Inc.	Methods for treating skin conditions
JP2002535394A (ja)	1999-01-27	2002-10-22	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	トリプターゼインヒビターとして有用なペプチジル複素環式ケトン
US20020034772A1 (en) *	1999-06-29	2002-03-21	Orlow Seth J.	Methods and compositions that affect melanogenesis
US7985404B1 (en)	1999-07-27	2011-07-26	Johnson & Johnson Consumer Companies, Inc.	Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
AU2012216795B2 (en) *	1999-11-05	2015-07-09	Johnson & Johnson Consumer Companies, Inc.	Soy depigmenting and skin care compositions
US7309688B2 (en)	2000-10-27	2007-12-18	Johnson & Johnson Consumer Companies	Topical anti-cancer compositions and methods of use thereof
MXPA01006891A (es) *	1999-11-05	2002-04-24	Johnson & Johnson	Composiciones de soya para el cuidado y despigmentacion de la piel.
US8431550B2 (en) *	2000-10-27	2013-04-30	Johnson & Johnson Consumer Companies, Inc.	Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) *	2001-02-28	2003-04-29	Johnson & Johnson Consumer Products, Inc.	Legume products
US7192615B2 (en)	2001-02-28	2007-03-20	J&J Consumer Companies, Inc.	Compositions containing legume products
US7025951B2 (en)	2002-06-18	2006-04-11	Johnson & Johnson Consumer Companies, Inc.	Compositions and methods for darkening the skin
US7141601B2 (en) *	2002-12-02	2006-11-28	Pola Chemiocal Industries Inc.	Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same
AU2003284491A1 (en) *	2002-12-03	2004-06-23	Pola Chemical Industries Inc.	Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same
CA2607142C (fr) *	2005-05-05	2014-03-25	Genencor International, Inc.	Compositions de soins personnels et methodes d'utilisation
FR2889808B1 (fr)	2005-08-17	2011-07-22	Oreal	Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee
US8026208B2 (en) *	2007-06-27	2011-09-27	The Board Of Trustees Of The Leland Stanford Junior University	Peptide tyrosinase inhibitors and uses thereof
JP2010160145A (ja) *	2008-12-12	2010-07-22	Daiichi Sankyo Healthcare Co Ltd	メラノソーム輸送の検出方法
US9326930B2 (en)	2009-01-16	2016-05-03	Neocutis S.A.	Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
US8084504B2 (en)	2009-10-02	2011-12-27	Johnson & Johnson Consumer Companies, Inc.	High-clarity aqueous concentrates of 4-hexylresorcinol
US20110081305A1 (en)	2009-10-02	2011-04-07	Steven Cochran	Compositions comprising a skin-lightening resorcinol and a skin darkening agent
US20110081430A1 (en)	2009-10-02	2011-04-07	Simarna Kaur	COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER
US8906432B2 (en)	2009-10-02	2014-12-09	Johnson & Johnson Consumer Companies, Inc.	Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
KR101286152B1 (ko) *	2010-12-17	2013-07-15	계명대학교 산학협력단	대두 추출물을 유효성분으로 포함하는 백반증 또는 백모의 개선용 조성물
KR102025923B1 (ko)	2011-11-04	2019-09-26	리포텍 에스.에이.	활성화된 수용체를 억제하는 펩티드 및 미용적 또는 약학적 조성물에서의 이의 용도
US20140086859A1 (en)	2012-09-24	2014-03-27	Johnson & Johnson Consumer Companies, Inc.	Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
JP2014153878A (ja) *	2013-02-07	2014-08-25	Nippon Telegr & Teleph Corp <Ntt>	エンド−エンド間本人性保証システム及び方法
JP6324777B2 (ja) *	2014-03-18	2018-05-16	ポーラ化成工業株式会社	コラーゲン産生促進剤
EP3200683A4 (fr) *	2014-09-29	2018-03-21	ELC Management LLC	Agents actifs stimulant la différenciation de kératinocytes dans le but d'éclaircir une peau hyperpigmentée
SG11201805765QA (en) *	2016-01-19	2018-08-30	Achromaz Pte Ltd	A cosmetic composition and the use thereof for regulating skin quality
CN106619167A (zh) *	2016-11-25	2017-05-10	南京泛成生物化工有限公司	一种美白提亮组合物、制备方法和在化妆品中的应用
WO2018162645A1 (fr)	2017-03-08	2018-09-13	Amazentis Sa	Méthodes de traitement de la peau
CN114375291B (zh)	2019-08-28	2024-03-08	联合利华知识产权控股有限公司	用于亮肤的新型化合物
MX2022002282A (es)	2019-08-28	2022-03-25	Unilever Ip Holdings B V	Compuestos novedosos para aclarar la piel.
KR20250047103A (ko)	2023-09-26	2025-04-03	부산대학교 산학협력단	머캅토 작용기를 가지는 화합물을 포함하는 미백용 조성물

Family Cites Families (362)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU695806B (en)	1906-09-19	1907-05-21	Leslie Campbell James	An improved adjustable comb for stripping and stripper harvesting machines
US2924525A (en) *	1957-06-03	1960-02-09	Central Soya Co	Poultry treatment for skin pigmentation
US2876164A (en) *	1957-08-01	1959-03-03	Dome Chemicals Inc	Dermatological preparation containing defatted soy bean flour
US3097947A (en)	1961-01-30	1963-07-16	Mend Johnson & Company	Nutritional composition and process
US3395214A (en)	1964-01-09	1968-07-30	Scholl Mfg Co Inc	Antiperspirant composition providing a readily collapsible sprayable foam
US4007266A (en)	1968-05-03	1977-02-08	Choay S.A.	Pharmaceutical composition containing vitamin B12, process of making the same and method of treatment
FR2041594A5 (fr)	1969-04-30	1971-01-29	Expanscience
US3625976A (en)	1969-12-09	1971-12-07	Int Flavors & Fragrances Inc	Coumarin ether sun-screening compounds
US3755560A (en)	1971-06-30	1973-08-28	Dow Chemical Co	Nongreasy cosmetic lotions
US4331692A (en)	1971-07-23	1982-05-25	Ulla Drevici	Cocoa fruits and products
GB1541463A (en)	1975-10-11	1979-02-28	Lion Dentifrice Co Ltd	Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4056637A (en)	1976-06-08	1977-11-01	Japan Natural Food Co. Ltd.	Process for preparing food products containing a lactic acid bacteria-fermented product of a cereal germ
US4151304A (en)	1976-11-05	1979-04-24	Lever Brothers Company	Method and composition for moisturizing the skin
FR2380775A1 (fr)	1977-02-22	1978-09-15	Sederma Sarl	Composition " apres-epilation " favorisant un ralentissement progressif de la repousse des poils
US4190671A (en)	1977-03-17	1980-02-26	Biorex Laboratories Limited	Chalcone derivatives
US4279930A (en)	1978-10-10	1981-07-21	The Upjohn Company	Process for treating inflammation
US4219569A (en)	1978-10-10	1980-08-26	The Upjohn Company	Process for treating inflammation
US4223018A (en)	1979-02-09	1980-09-16	Jimmie Belle	Bath composition
IT8021120A0 (it)	1979-04-02	1980-04-01	Inst Organicheskogo Sinteza Ak	Analogo ciclico del peptide naturale stimolante la fagocitosi: treonile-ciclo (n-lisile-prolile-arginile).
DE3040246C2 (de)	1979-10-29	1985-01-10	Osaka Chemical Laboratory Co., Ltd., Osaka	Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
JPS56135416A (en)	1980-03-27	1981-10-22	Mitsubishi Chem Ind Ltd	Pharmaceutical preparation for skin
US4297348A (en)	1980-04-11	1981-10-27	Rush-Hampton Industries, Inc.	Composition and method for the treatment of acne
US5439672A (en)	1980-07-01	1995-08-08	L'oreal	Cosmetic composition based on an aqueous dispersion of small lipid spheres
US4278570A (en)	1980-08-20	1981-07-14	Eli Lilly And Company	Cosmetic cleanser formulation
US4272544A (en)	1980-08-20	1981-06-09	Eli Lilly And Company	Skin cell renewal regime
LU83020A1 (fr)	1980-12-19	1982-07-07	Oreal	Composition huileuse destinee au traitement des matieres keratiniques et de la peau
DE3109420A1 (de)	1981-03-12	1982-09-23	Kastell, Wolfgang, 2000 Hamburg	Mittel zum anhalten des haarausfalls und zum foerdern des haarwuchses
FR2509988B1 (fr)	1981-07-23	1986-05-30	Oreal	Melange d'huiles vegetales a base d'huile de jojoba comme agent de stabilisation a l'oxydation et compositions cosmetiques le contenant
DE3129867A1 (de)	1981-07-29	1983-02-17	Henkel Kgaa	"ungesaettigte arylketone als antiseborrhoische zusaetze fuer kosmetische mittel"
US4368187A (en)	1981-08-03	1983-01-11	Eli Lilly And Company	Sensitive-skin care regime
US4382960A (en)	1981-08-03	1983-05-10	Eli Lilly And Company	Cosmetic cleanser formulation
US4603146A (en)	1984-05-16	1986-07-29	Kligman Albert M	Methods for retarding the effects of aging of the skin
US4859458A (en)	1981-09-15	1989-08-22	Morton Thiokol, Inc.	Hair conditioning polymers containing alkoxylated nitrogen salts of sulfonic acid
US4578267A (en)	1981-09-15	1986-03-25	Morton Thiokol, Inc.	Skin conditioning polymer containing alkoxylated nitrogen salts of sulfonic acid
US4421769A (en)	1981-09-29	1983-12-20	The Procter & Gamble Company	Skin conditioning composition
FR2514643B1 (fr)	1981-10-20	1986-07-04	Oreal	Lanolate de cuivre et compositions cosmetiques anti-acneiques le contenant
FR2520253A1 (fr)	1982-01-28	1983-07-29	Oreal	Nouveau systeme emulsionnant a base d'un condensat de proteines, d'un sterol polyoxyethylene et de phosphatide et son utilisation en cosmetique
US4477434A (en)	1982-05-29	1984-10-16	Reiko Kosaka	Medicinal compositions, foods and beverages having therapeutic effects on diseases of circulatory system and digestive system
US4550035A (en)	1982-12-10	1985-10-29	Creative Products Resource Associates, Ltd.	Cosmetic applicator useful for skin moisturizing and deodorizing
US4462981A (en)	1982-12-10	1984-07-31	Creative Products Resource, Associates Ltd.	Cosmetic applicator useful for skin moisturizing and deodorizing
US4604281A (en)	1983-03-21	1986-08-05	Charles Of The Ritz Group Ltd.	Cosmetic and skin treatment compositions containing acetylated sterols
DE3326455A1 (de)	1983-07-22	1985-01-31	Henkel Kgaa	Kosmetisch-pharmazeutische oelkomponenten
JPS6061513A (ja)	1983-09-14	1985-04-09	Sansho Seiyaku Kk	化粧料
US4512973A (en)	1983-10-12	1985-04-23	Genentech, Inc.	Method for overcoming trypsin inhibition
US5192332A (en)	1983-10-14	1993-03-09	L'oreal	Cosmetic temporary coloring compositions containing protein derivatives
JPS60109544A (ja)	1983-11-17	1985-06-15	Kao Corp	新規カルコン誘導体及びこれを含有する紫外線吸収剤
IT1180156B (it)	1984-01-09	1987-09-23	Crinos Industria Farmaco	Composizione cosmetica a base di glicoproteine per il trattamento della pelle
US4678663A (en)	1984-02-06	1987-07-07	Nuetrogena Corporation	Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4690821A (en)	1984-02-10	1987-09-01	Creative Products Resource Associates, Ltd.	Towel for skin moisturizing and drying
ATE81449T1 (de)	1984-03-05	1992-10-15	Tonfer Inc	Reinigungsmittel.
AU580645B2 (en)	1984-12-21	1989-01-19	Kibun Company Limited	Process of producing soy bean milk
FR2580478B1 (fr)	1985-04-17	1989-05-12	Christian Chapoton	Dispositif de traitement capillaire liberant une substance active et procede de fabrication
US4760096A (en)	1985-09-27	1988-07-26	Schering Corporation	Moisturizing skin preparation
US4793991A (en)	1986-01-31	1988-12-27	Slimak Karen M	Hypoallergenic cosmetics, lip balms and lip sticks
US4847267A (en)	1986-03-17	1989-07-11	Charles Of The Ritz Group Ltd.	Skin treatment composition and method
US4970216A (en)	1986-03-17	1990-11-13	Richardson Vicks, Inc.	Skin treatment composition and method
LU86361A1 (fr)	1986-03-19	1987-11-11	Oreal	Composition cosmetique aqueuse a moussage differe pour le traitement des cheveux et de la peau
FR2641696B2 (fr)	1986-04-11	1991-03-08	Sederma Sa	Utilisation d'un melange renfermant de la lactoferrine dans des preparations cosmetiques anti-radicaux libres
FR2596986B1 (fr)	1986-04-11	1988-09-23	Sederma Sa	Utilisation de la lactoferrine dans des preparations cosmetiques, antiradicaux libres
FR2600250B1 (fr)	1986-06-23	1989-11-24	Bio Serae	Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee
JPS63135310A (ja)	1986-11-27	1988-06-07	Lion Corp	化粧料
LU86715A1 (fr)	1986-12-16	1988-07-14	Oreal	Composition cosmetique contenant des derives hydroxyles de chalcone et son utilisation pour la protection de la peau et des cheveux contre les radiations lumineuses,nouveaux derives hydroxyles de chalcone utilises et leur procede de preparation
AU618517B2 (en)	1986-12-23	1992-01-02	Eugene J. Van Scott	Additives enhancing topical actions of therapeutic agents
IT1201149B (it)	1987-01-14	1989-01-27	Indena Spa	Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1203515B (it)	1987-02-26	1989-02-15	Indena Spa	Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
US5166139A (en)	1987-02-26	1992-11-24	Indena, S.P.A.	Complexes of saponins and their aglycons with phospholipids and pharmaceutical and cosmetic compositions containing them
US4960764A (en)	1987-03-06	1990-10-02	Richardson-Vicks Inc.	Oil-in-water-in-silicone emulsion compositions
DE3712986A1 (de)	1987-04-16	1988-10-27	Marbert Gmbh	Medizinische zubereitungen auf der grundlage von biertreberextrakt, verfahren zu deren herstellung sowie verwendung von biertreberextrakt zur herstellung von kosmetischen zubereitungen und ein spezieller biertreberextrakt
US5057417A (en)	1987-06-12	1991-10-15	Genentech, Inc.	Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
US5688763A (en)	1987-06-12	1997-11-18	Hammonds, Jr.; R. Glenn	Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
US4824662A (en)	1987-06-15	1989-04-25	Vi-Jon Laboratories, Inc.	Nail polish remover
IT1222012B (it)	1987-07-10	1990-08-31	Indena Spa	Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi
IT1223290B (it)	1987-07-27	1990-09-19	Indena Spa	Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
LU86997A1 (fr)	1987-09-21	1989-04-06	Oreal	Composition cosmetique filtrante photostable contenant de la bixine associee a un filtre uv liposoluble et son utilisation pour la protection de l'epiderme humain contre les radiations ultraviolettes
JP2618657B2 (ja)	1987-10-02	1997-06-11	株式会社資生堂	抗色素沈着外用剤
JPH0196106A (ja)	1987-10-09	1989-04-14	Shiseido Co Ltd	皮膚外用剤
US4915972A (en) *	1988-01-05	1990-04-10	Prosoya Corporation	Food processing in oxygen-free environment
CH676470A5 (fr)	1988-02-03	1991-01-31	Nestle Sa
FR2628317B1 (fr)	1988-03-09	1991-11-08	Lvmh Rech	Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
DE3814839A1 (de)	1988-05-02	1989-11-16	Henkel Kgaa	Haarbehandlungsmittel mit natuerlichen inhaltsstoffen
IT1219587B (it)	1988-05-13	1990-05-18	Fidia Farmaceutici	Polisaccaridi carbossiilici autoreticolati
US4906457A (en)	1988-09-06	1990-03-06	Washington State University Research Foundation, Inc.	Compositions and methods for reducing the risk of sunlight and ultraviolet induced skin cancer
US4851214A (en)	1988-09-07	1989-07-25	Ici Americas Inc.	Deodorants containing N-soya-N-ethyl morpholinium ethosulfate
US4960588A (en)	1988-11-16	1990-10-02	Helene Curtis, Inc.	Hair treatment compositions to impart durable hair set retention properties
US4943462A (en)	1989-01-17	1990-07-24	Semex Medical, Inc.	Nail treatment device
LU87449A1 (fr)	1989-02-09	1990-09-19	Oreal	Procede de fabrication de mousses utilisables dans les domaines cosmetique et pharmaceutique et mousses obtenues par ce procede
US5116605A (en)	1989-03-09	1992-05-26	Alt John P	Composition and skin treatment method therewith for mitigating acne and male-pattern baldness
AU631425B2 (en)	1989-04-14	1992-11-26	Wesley-Jessen Corporation	Color binding mechanism for contact lenses
MY105521A (en)	1989-04-17	1994-10-31	Healthpoint Ltd	Moisturizing vehicle for topical application of vitamin a acid.
US5077038A (en)	1989-07-27	1991-12-31	Vi-Jon Laboratories, Inc.	Nail polish remover
US5194252A (en)	1989-07-27	1993-03-16	Vijon Laboratories, Inc.	Moisture retaining aftershave
EP0443005A4 (en)	1989-09-14	1992-02-19	Sing-Hsiung Chang	Soft gas permeable contact lens having improved clinical performance
JP2832848B2 (ja)	1989-10-21	1998-12-09	株式会社林原生物化学研究所	結晶２―Ｏ―α―Ｄ―グルコピラノシル―Ｌ―アスコルビン酸とその製造方法並びに用途
EP0421021A1 (fr)	1989-10-06	1991-04-10	MUCOS EMULSIONSGESELLSCHAFT m.b.H.	Utilisation d'enzymes cataboliques pour l'activation des macrophages et/ou des cellules NK, composition pharmaceutique contenant ces enzymes pour l'activation des macrophages et/ou des cellules NK
US5554647A (en)	1989-10-12	1996-09-10	Perricone; Nicholas V.	Method and compositions for treatment and/or prevention of skin damage and aging
US5032400A (en)	1989-11-02	1991-07-16	Erie Laboratories	Shark liver oil and garlic oil topical analgesic
US5834312A (en)	1990-01-29	1998-11-10	Hy-Gene, Inc.	Process and media for the growth of human epithelia
US5622690A (en)	1990-04-05	1997-04-22	Nurture, Inc.	Seed-derived proteinaceous compositions for reduction of sunburn cell formation
US5077040A (en)	1990-04-30	1991-12-31	Helene Curtis, Inc.	Hair-treating microemulsion composition and method of preparing and using the same
FR2663633B1 (fr)	1990-06-22	1994-06-17	Adir	Nouvelles chalcones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5332758A (en)	1990-07-13	1994-07-26	Kanebo, Ltd.	Collagen metabolism ameliorant and its use
CA2047160C (fr)	1990-07-25	2002-06-25	Masahiro Ito	Composition d'etancheite elastique thermo-fusible reactive
US5231090A (en)	1990-07-30	1993-07-27	University Of Miami	Treatment for hypercholesterolemia
US5407675A (en)	1990-08-10	1995-04-18	Etemad-Moghadam; Parviz	Method and composition for use on the scalp and eyebrow region of a subject
CA2049728A1 (fr)	1990-08-24	1992-02-25	Kenji Kitamura	Composition de lavage capable de prevenir et d'ameliorer les irritations de la peau
JPH04169520A (ja) *	1990-11-01	1992-06-17	Shiseido Co Ltd	皮膚洗浄料組成物
FR2666474B1 (fr)	1990-08-28	1992-11-06	De Stoutz Jean	Dispositif pour le chauffage de fluides par effet joule.
US5217717A (en)	1990-09-06	1993-06-08	Central Soya Company, Inc.	Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy
US5130142A (en)	1990-10-31	1992-07-14	The Practer & Gamble Company	Hair growth regulating composition comprising epithelium cell supernatant-derived growth factor
JP3032566B2 (ja) *	1990-11-01	2000-04-17	株式会社資生堂	皮膚外用剤
EP0510165B1 (fr)	1990-11-14	1995-01-25	L'oreal	Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes
CA2095046C (fr)	1990-11-27	2003-01-28	Paul L. Valint, Jr.	Macromonomeres tensio-actifs
US5135297A (en)	1990-11-27	1992-08-04	Bausch & Lomb Incorporated	Surface coating of polymer objects
US5110603A (en)	1991-01-31	1992-05-05	Kao Corporation	Bathing preparation for colloidal material
US5188823A (en)	1991-02-07	1993-02-23	Stepan Company	Antiperspirant formulations
US5449794A (en)	1991-02-15	1995-09-12	Jasmine Fockerman	Benzopyran phenol derivatives for use as antibacterial agents
GB9104286D0 (en)	1991-02-28	1991-04-17	Phytopharm Ltd	Pharmaceutical compositions for the treatment of skin disorders
US5807543A (en)	1993-08-27	1998-09-15	The Procter & Gamble Co.	Cosmetic compositions containing hydrophobically modified nonionic polymer and unsaturated quaternary ammonium surfactant
JPH05114905A (ja)	1991-04-08	1993-05-07	Digital Equip Corp <Dec>	単一アドレス及びプロトコール・テーブル・ブリツジを使用したメツセージの処置フイルタリング
US5498420A (en)	1991-04-12	1996-03-12	Merz & Co. Gmbh & Co.	Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
US5229104A (en)	1991-04-29	1993-07-20	Richardson-Vicks Inc.	Artificial tanning compositions containing positively charged paucilamellar vesicles
EP0514576A1 (fr)	1991-05-24	1992-11-25	Societe Des Produits Nestle S.A.	Mélange antioxydant liposoluble
US5310734A (en)	1991-07-05	1994-05-10	Rhone-Poulenc Rorer	Phospholipid composition
JP3320430B2 (ja)	1991-07-10	2002-09-03	日本原子力研究所	放射線滅菌による無菌リン脂質、リン脂質水分散液又はリポソーム水分散液の製造法
FR2679446B1 (fr)	1991-07-24	1993-10-29	Oreal	Procede de fabrication d'une composition cosmetique pour application sur les cheveux, composition obtenue par ce procede et procede de traitement cosmetique a l'aide de ladite composition.
FR2679904A1 (fr)	1991-08-01	1993-02-05	Lvmh Rech	Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
US5254331A (en)	1991-09-12	1993-10-19	Chanel, Inc.	Skin cream composition
DE59209963D1 (de) *	1991-09-13	2002-08-14	Pentapharm Ag Basel	Proteinfraktion zur kosmetischen und dermatologischen Pflege der Haut
US5260065A (en)	1991-09-17	1993-11-09	Micro Vesicular Systems, Inc.	Blended lipid vesicles
US5780459A (en)	1991-11-25	1998-07-14	The Procter & Gamble Company	Compositions for regulating skin wrinkles and or skin atrophy
AU3073692A (en)	1991-11-25	1993-06-28	Richardson-Vicks Inc.	Compositions for regulating skin wrinkles and/or skin atrophy
EP0614354B1 (fr)	1991-11-25	2001-01-17	Richardson-Vicks, Inc.	Emploi d'acide salicylique contre l'atrophie cutanee
FR2685202B1 (fr)	1991-12-24	1995-03-24	Sederma Sa	Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee.
FR2687314A1 (fr)	1992-02-18	1993-08-20	Oreal	Dispersion de vesicules lipidiques, composition cosmetique et/ou pharmaceutique la contenant et procede de preparation de ladite dispersion.
US5766628A (en)	1992-02-24	1998-06-16	Merz + Co. Gmbh & Co.	Bath and shower composition having vesicle-forming properties and method for the production and use thereof
DE4206090C2 (de)	1992-02-27	1998-02-05	Perycut Chemie Ag	Insektenabwehrmittel
US5322689A (en)	1992-03-10	1994-06-21	The Procter & Gamble Company	Topical aromatic releasing compositions
US5393519A (en)	1992-03-27	1995-02-28	Helene Curtis, Inc.	Shampoo compositions
US5248495A (en)	1992-04-16	1993-09-28	The Procter & Gamble Company	Post foaming shaving gel composition
EP0574352A1 (fr)	1992-06-09	1993-12-15	Ciba-Geigy Ag	Procédé de polymérisation par greffage sur les surfaces de substrats préformés afin de modifier leurs propriétés de surface
US5352443A (en)	1992-06-15	1994-10-04	Shiseido Co., Ltd.	Permanent waving composition
FR2692783B1 (fr)	1992-06-25	1995-05-05	Expanchimie	Compositions à base de fractions insaponifiables d'huiles de germe de blé et de sésame, et leurs utilisations notamment en cosmétologie et en qualité de complément alimentaire.
DE4221256C2 (de)	1992-06-26	1997-07-10	Lancaster Group Ag	Galenische Zusammensetzung für die topische Anwendung
US5641509A (en)	1992-06-26	1997-06-24	Lancaster Group Ag	Preparation for topical use
US5643601A (en)	1992-06-26	1997-07-01	Lancaster Group Ag	Phospholipid-and fluorocarbon-containing cosmetic
US5438044A (en)	1992-06-30	1995-08-01	Rhone-Poulenc Rorer	Phospholipid composition
ES2136105T3 (es)	1992-08-04	1999-11-16	Rhone Poulenc Rorer Gmbh	Preparacion farmaceutica y/o cosmetica.
DE4226173A1 (de)	1992-08-07	1994-02-10	Solvay Fluor & Derivate	Badezusatzpräparat
FR2694934B1 (fr)	1992-08-24	1994-11-10	Oreal	Composition pour le traitement de l'acné contenant un dérivé d'acide salicylique et dérivés d'acide salicylique.
JPH06192085A (ja)	1992-08-31	1994-07-12	Yuji Inada	ダニアレルギー治療剤
IL106922A (en)	1992-09-14	1998-08-16	Novartis Ag	Composite materials with one or more wettable surfaces and process for their preparation
US6048520A (en)	1992-09-24	2000-04-11	Helene Curtis, Inc.	Clear leave-on hair treatment composition and method
US5753612A (en)	1992-10-27	1998-05-19	Yissum Research Development Co. Of The Hebrew University Of Jerusalem	Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
JP3257091B2 (ja)	1992-11-06	2002-02-18	不二製油株式会社	抗皮膚癌剤又は食品
US5565439A (en)	1992-11-24	1996-10-15	The Procter & Gamble Company	Methods of using lysophosphatidic acid for treating hyperproliferative conditions
JP2580942B2 (ja)	1992-12-24	1997-02-12	ティアック株式会社	磁気テ−プ装置及びこの磁気ヘッドの移動方法
US5270042A (en)	1993-02-23	1993-12-14	Juanita Whitham	Medicinal salve composition
RU2066992C1 (ru)	1993-03-01	1996-09-27	Надежда Михайловна Остроумова	Средство для удаления волос "пластилин каприз" и способ его получения
JP3091045B2 (ja) *	1993-03-04	2000-09-25	丸善製薬株式会社	皮膚化粧料
CA2119064A1 (fr)	1993-03-17	1994-09-18	Richard A. Berg	Systeme d'analyse dermo-epidermique in vitro
CN1081899A (zh)	1993-04-24	1994-02-16	王丽华	广灵药膏
US5276058A (en)	1993-06-09	1994-01-04	Nippon Hypox Laboratories Incorporated	3,4-dihydroxychalcone derivatives
TW253849B (fr)	1993-08-09	1995-08-11	Ciba Geigy
ES2185638T3 (es)	1993-08-30	2003-05-01	Unilever Nv	Composicion de champu acondicionador.
FR2709756B1 (fr)	1993-09-10	1995-10-20	Essilor Int	Matériau hydrophile, transparent à haute perméabilité à l'oxygène, à base d'un polymère à réseaux interpénétrés, son mode de préparation et fabrication de lentilles de contact souples à haute perméabilité à l'oxygène.
FR2710264B1 (fr)	1993-09-21	1995-12-08	Rocher Yves Biolog Vegetale	Utilisation pour le traitement des peaux mixtes d'une quantité efficace de substances actives.
FR2710524B1 (fr)	1993-09-28	1995-11-17	Oreal	Composition de vernis à ongles contenant une huile époxydée comme plastifiant.
US5641863A (en)	1993-09-30	1997-06-24	University Of Pennsylvania	Chimeric IgG Fc receptors
IL111105A (en)	1993-09-30	2009-05-04	Univ Pennsylvania	Use of a molecule capable of inhibiting the expression of syk kinase to prepare a pharmaceutical composition for inhibiting phagocytosis
US5681571A (en)	1993-10-08	1997-10-28	Duotol Ab	Immunological tolerance-inducing agent
JPH07121869B2 (ja)	1993-10-12	1995-12-25	浩前田	炎症性浮腫亢進抑制剤
US5510391A (en)	1993-10-22	1996-04-23	Mayapple Holdings, Llc	Method of treating blood vessel disorders of the skin using vitamin K
GB9322007D0 (en)	1993-10-26	1993-12-15	Unilever Plc	Cosmetic composition
US5681852A (en)	1993-11-12	1997-10-28	The Procter & Gamble Company	Desquamation compositions
EP0655470B1 (fr)	1993-11-26	1999-05-12	Novartis AG	Copolymères réticulables et hydrogels
US5712356A (en)	1993-11-26	1998-01-27	Ciba Vision Corporation	Cross-linkable copolymers and hydrogels
DE4343431C1 (de)	1993-12-18	1995-05-04	Henkel Kgaa	Kosmetische und/oder pharamzeutische Zubereitungen
DE69402297T2 (de)	1993-12-22	1997-07-10	Oreal	Kosmetisches oder dermatologisches Pulver, Verfahren zu seiner Herstellung und Verwendungen
US5620692A (en)	1993-12-23	1997-04-15	Nurture, Inc.	Oat oil compositions with useful cosmetic and dermatological properties
JPH07196527A (ja)	1993-12-29	1995-08-01	Morinaga Milk Ind Co Ltd	ペプチドまたはその誘導体と、細胞増殖賦活化剤
JPH07196529A (ja)	1993-12-29	1995-08-01	Morinaga Milk Ind Co Ltd	創傷治癒剤、化粧料および養毛剤
FR2714600B1 (fr)	1993-12-30	1996-02-09	Oreal	Composition protectrice, nutritive et/ou raffermissante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
FR2714599B1 (fr)	1993-12-30	1996-02-09	Oreal	Composition pour lutter contre le vieillissement, agissant siimultanément sur les couches superficielles et profondes de la peau, son utilisation.
FR2714597B1 (fr)	1993-12-30	1996-02-09	Oreal	Composition hydratante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
FR2714602B1 (fr)	1993-12-30	1996-02-09	Oreal	Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
FR2714604B1 (fr)	1993-12-30	1996-01-26	Oreal	Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.
FR2714601B1 (fr)	1993-12-30	1996-02-09	Oreal	Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.
FR2714598B1 (fr)	1993-12-30	1996-02-09	Oreal	Composition amincissante à deux types de liposomes pour traitement topique, son utilisation.
FR2714596B1 (fr)	1993-12-30	1996-02-09	Oreal	Composition cosmétique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
JPH0899891A (ja) *	1994-01-21	1996-04-16	Pola Chem Ind Inc	皮膚外用剤
US5468473A (en)	1994-02-09	1995-11-21	Innova Products, Inc.	Antiperspirant for hands and feet
FR2716079B1 (fr)	1994-02-15	1996-05-03	Stoutz Jean Christian De	Procédé d'extraction de matières solubles de fèves ou graines d'oléagineux, notamment procédé de production de "lait" de soja.
DE4405127A1 (de)	1994-02-18	1995-08-31	Henkel Kgaa	Haarbehandlungsmittel
IL112649A (en)	1994-02-22	1999-12-22	Curtis Helene Ind Inc	Topically effective compositions for application to the skin or hair
US5547661A (en)	1994-02-22	1996-08-20	Helene Curtis, Inc.	Antiperspirant deodorant compositions
FR2717075B1 (fr)	1994-03-14	1996-04-05	Oreal	Gel aqueux de maquillage à organopolysiloxane.
US5455234A (en)	1994-03-16	1995-10-03	Ahluwalia; Gurpreet S.	Inhibition of hair growth
US5505946A (en)	1994-04-01	1996-04-09	Trustees Of Univ Of Pa	Bowman-birk inhibitor concentrate compositions and methods for the treatment of pre-malignant tissue
US6013255A (en)	1994-04-18	2000-01-11	Gist-Brocades B.V.	Stable water-in-oil emulsions
FR2719219B1 (fr)	1994-05-02	1996-06-21	Rocher Yves Biolog Vegetale	Composition cosmétique ou pharmaceutique à usage topique comprenant des vésicules lipidiques.
JP3127713B2 (ja)	1994-05-10	2001-01-29	株式会社村田製作所	粉末成形の最適条件解析方法
JPH07304655A (ja)	1994-05-13	1995-11-21	Kikkoman Corp	入浴剤及びその製造法
FR2720937B1 (fr)	1994-06-08	1997-03-28	Oreal	Composition cosmétique ou dermatologique sous forme de dispersion, aqueuse et stable, de particules de gel cubique à base de phytantriol et contenant un agent tensioactif à chaîne grasse en tant qu'agent dispersant et stabilisant.
FR2720934B1 (fr)	1994-06-14	1996-07-12	Oreal	Emulsion nettoyante huile-dans-eau ayant l'aspect d'un lait.
JPH0812560A (ja)	1994-06-29	1996-01-16	Shiseido Co Ltd	皮膚外用剤
DE4424210C2 (de)	1994-07-09	1997-12-04	Beiersdorf Ag	Verwendung von Zusammensetzungen mit einem Gehalt an Tensiden sowie einem Gehalt an Ölkomponenten, die im übrigen wasserfrei sind, als kosmetische oder dermatologische Duschöle
GB9414045D0 (en)	1994-07-12	1994-08-31	Berwind Pharma Service	Moisture barrier film coating composition, method, and coated form
US5444092A (en)	1994-07-20	1995-08-22	Collins; Jerry	Method and composition for treating psoriasis
JPH0859450A (ja)	1994-08-18	1996-03-05	Kose Corp	皮膚外用剤
DE4433071C1 (de)	1994-09-16	1995-12-21	Henkel Kgaa	Milde Detergensgemische
US5554608A (en)	1994-09-28	1996-09-10	Ahluwalia; Gurpreet S.	Inhibition of hair growth
JPH08143442A (ja)	1994-11-16	1996-06-04	Kikkoman Corp	皮膚外用剤及びその製造法
US5567420A (en)	1994-11-16	1996-10-22	Mceleney; John	Lotion which is temporarily colored upon application
JP3647093B2 (ja)	1994-11-17	2005-05-11	株式会社メニコン	親水性化酸素透過性コンタクトレンズ及びその製造法
DE69509554T2 (de)	1994-12-06	1999-12-23	The Procter & Gamble Co., Cincinnati	Lagerbeständige flüssige hautreinigungszusammensetzung mit gelbindenden polymeren, lipiden und athylenglykolfettsäureestern
EP0796083A1 (fr)	1994-12-06	1997-09-24	The Procter & Gamble Company	Demaquillant liquide a longue duree de conservation contenant un polymere formant gel et des lipides
DE4444238A1 (de)	1994-12-13	1996-06-20	Beiersdorf Ag	Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
GB9500116D0 (en)	1995-01-05	1995-03-01	Ciba Geigy Ag	Pharmaceutical compositions
US5618522A (en)	1995-01-20	1997-04-08	The Procter & Gamble Company	Emulsion compositions
US6129956A (en)	1995-02-07	2000-10-10	Fidia Advanced Bioplymers, Srl	Process for the coating of objects with hyaluronic acid, derivatives thereof, and semisynthetic polymers
CA2213235A1 (fr)	1995-02-15	1996-08-22	The Procter & Gamble Company	Cires cristallines hydroxylees utilisees comme stabilisateurs h-l pour composition nettoyante liquide
FR2730928B1 (fr)	1995-02-23	1997-04-04	Oreal	Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
CA2210524A1 (fr)	1995-03-23	1996-09-26	Lancaster Group Gmbh	Produit cosmetique avec produits de decomposition condenses d'origine vegetale et animale
FR2731907B1 (fr)	1995-03-23	1997-06-20	Fabre Pierre Dermo Cosmetique	Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
FR2733148B1 (fr)	1995-04-20	1997-05-30	Oreal	Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations
US5985809A (en)	1995-05-27	1999-11-16	The Procter & Gamble Company	Aqueous personal cleansing compositions comprising specific nonocclusive liquid polyol fatty acid polyester
GB9510833D0 (en)	1995-05-27	1995-07-19	Procter & Gamble	Cleansing compositions
US5942479A (en)	1995-05-27	1999-08-24	The Proctor & Gamble Company	Aqueous personal cleansing composition with a dispersed oil phase comprising two specifically defined oil components
JP3911642B2 (ja)	1995-06-06	2007-05-09	株式会社加美乃素本舗	皮膚外用剤
US5523308A (en) *	1995-06-07	1996-06-04	Costanzo; Michael J.	Peptidyl heterocycles useful in the treatment of thrombin related disorders
EP0831875A4 (fr)	1995-06-07	2002-07-31	Univ Pennsylvania	Procedes d'inhibition de la phagocytose
US5639785A (en)	1995-06-07	1997-06-17	Global Pharma, Ltd.	Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
CA2223747A1 (fr)	1995-06-07	1996-12-19	Taisho Pharmaceutical Co., Ltd.	Agent antifongique
DE69600059T2 (de)	1995-06-21	1998-02-05	Oreal	Kosmetisches Mittel enthaltend eine Dispersion von Polymerenteilchen
JPH0840824A (ja)	1995-06-21	1996-02-13	Nonogawa Shoji Kk	化粧料
US6126933A (en)	1995-06-27	2000-10-03	Genetics Institute	Methods of treating inflammatory bowel diseases by administering IL-11
US6013250A (en)	1995-06-28	2000-01-11	L'oreal S. A.	Composition for treating hair against chemical and photo damage
CN1146876A (zh)	1995-06-28	1997-04-09	李缯宏	美容豆奶
JP3410870B2 (ja)	1995-07-13	2003-05-26	株式会社資生堂	皮膚外用剤
JPH0925213A (ja)	1995-07-13	1997-01-28	Shiseido Co Ltd	皮膚外用剤
JPH0925212A (ja)	1995-07-13	1997-01-28	Shiseido Co Ltd	皮膚外用剤
US5571503A (en)	1995-08-01	1996-11-05	Mausner; Jack	Anti-pollution cosmetic composition
US5874127A (en)	1995-08-16	1999-02-23	Ciba Vision Corporation	Method and apparatus for gaseous treatment
JPH0977638A (ja)	1995-09-19	1997-03-25	Art Beauty Clinic Kk	化粧用ファンデーション
US6063398A (en)	1995-09-20	2000-05-16	L'oreal	Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent
US5683683A (en)	1995-09-21	1997-11-04	Helene Curtis, Inc.	Body wash composition to impart conditioning properties to skin
US5635165A (en)	1995-09-27	1997-06-03	Helene Curtis, Inc.	Antiperspirant deodorant compositions
US5885593A (en)	1995-09-28	1999-03-23	The Andrew Jergens Company	Skin care composition including cyclodextrin materials and method for treating skin therewith
EP0798305B1 (fr)	1995-10-17	2007-10-03	Showa Denko Kabushiki Kaisha	Phosphates de tocopherol tres purs, procedes de preparation, techniques d'analyse et produits cosmetiques correspondants
NZ299379A (en)	1995-10-27	1997-04-24	Unilever Plc	Topical flavanone-containing composition
US6238678B1 (en)	1995-11-06	2001-05-29	The Procter & Gamble Company	Methods of regulating skin appearance with vitamin B3 compound
US6019962A (en)	1995-11-07	2000-02-01	The Procter & Gamble Co.	Compositions and methods for improving cosmetic products
US6509098B1 (en)	1995-11-17	2003-01-21	Massachusetts Institute Of Technology	Poly(ethylene oxide) coated surfaces
EP0811595B1 (fr)	1995-11-24	2001-02-07	Mitsui Chemicals, Inc.	Derives d'hydrochalcone, compositions cosmetiques les contenant et procedes de preparation de ces derives ou compositions
US5961980A (en)	1996-01-18	1999-10-05	The Trustees Of The University Of Pennsylvania	Bowman-birk inhibitor compositions and methods for the treatment of genitourinary diseases
US5643587A (en)	1996-02-15	1997-07-01	Avon Products, Inc.	Composition and method for under-eye skin lightening
CN1146665C (zh) *	1996-03-28	2004-04-21	波士顿大学托管委员会	调控黑色素合成的方法
EP0907351B2 (fr)	1996-03-29	2012-04-18	Keyvest GmbH	Cosmetique ou preparation cosmetique pour le lissage et la tension de la peau en cas d'affections du tissu adipeux sous-cutane, en particulier en cas de cellulite
FR2747568B1 (fr)	1996-04-17	1999-09-17	Oreal	Utilisation d'au moins un inhibiteur de lipoxygenase et d'au moins un inhibiteur de cyclo-oxygenase pour modifier la pousse des poils et/ou des cheveux
EP0896522B1 (fr)	1996-04-23	2003-10-22	The Procter & Gamble Company	Methodes de traitement et d'amelioration de l'aspect de la peau au moyen d'un compose a la vitamine b 3
US5834513A (en)	1996-04-25	1998-11-10	Avon Products, Inc.	Oxa diacids and related compounds for treating skin conditions
CN1166960A (zh)	1996-06-04	1997-12-10	金建文	螺旋藻复合美容面膜粉
US5824702A (en)	1996-06-07	1998-10-20	Mount Sinai School Of Medicine Of The City University Of New York	Genistein as a preventive against ultraviolet induced skin photodamage and cancer
US5821361A (en)	1996-06-11	1998-10-13	Protein Technologies International, Inc.	Recovery of isoflavones from soy molasses
EP0814116A1 (fr)	1996-06-19	1997-12-29	Hüls Aktiengesellschaft	Revêtement hydrophilique de surfaces de substrats polymères
BR9602991A (pt)	1996-07-05	1998-04-28	Cosmeticos Natural Ind Com	Composições cosméticas hidratantes e protetoras da pele contra as radiações ultravioleta e infravermelha
BR9603084A (pt)	1996-07-12	1998-05-05	Cosmeticos Natural Ind Com	Composição secativa em forma de emulsão para a pele
CA2260966A1 (fr) *	1996-07-12	1998-01-22	Johnson & Johnson Consumer Companies, Inc.	Procedes pour modifier la croissance capillaire et la pigmentation capillaire par apoptose dans les papilles folliculaires et compositions prevues a cet effet
US5888522A (en)	1996-08-23	1999-03-30	Skin Biology, Inc.	Tissue protective and regenerative compositions
JPH10120560A (ja)	1996-08-26	1998-05-12	Sankyo Co Ltd	ロキソプロフェン含有外用製剤
US5804234A (en)	1996-09-13	1998-09-08	Suh; John D.	Plant protein for nutritional products and method of making same
DE19638534A1 (de)	1996-09-20	1998-03-26	Beiersdorf Ag	Verwendung von Tocopherylferulat zur Hautaufhellung oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung
FR2753626B1 (fr)	1996-09-20	1998-11-06	Centre International De Rech Dermatologiques Galderma Cird Galderma	Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
US5665367A (en)	1996-09-27	1997-09-09	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Skin care compositions containing naringenin and/or quercetin and a retinoid
FR2754713B1 (fr)	1996-10-22	1999-01-08	Roc Sa	Utilisation de complexes pour la preparation de compositions pour le traitement des peaux sensibles, procede de preparation et compositions hypoallergeniques
IL119535A (en)	1996-10-31	2001-01-11	Chajuss Daniel	Soy molasses and modified soy molasses for topical application
US6593290B1 (en)	1996-11-01	2003-07-15	Genentech, Inc.	Treatment of inner ear hair cells
JPH10139654A (ja) *	1996-11-08	1998-05-26	Lion Corp	皮膚外用組成物
IT1288257B1 (it)	1996-11-29	1998-09-11	Paoli Ambrosi Gianfranco De	Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
FR2757767B1 (fr)	1996-12-27	1999-02-05	Oreal	Composition topique contenant au moins une proteine d'origine vegetale et/ou une proteine d'origine animale et une poly(acide 2-acrylamido 2-methylpropane sulfonique) reticule
US6018001A (en)	1997-01-23	2000-01-25	Menicon Co., Ltd.	Process for producing contact lens with hydrophilic surface and contact lens obtained thereby
US5863546A (en)	1997-03-02	1999-01-26	Swinehart; James M	Cosmetic composition
US5885600A (en)	1997-04-01	1999-03-23	Burlington Bio-Medical & Scientific Corp.	Natural insect repellent formula and method of making same
US5962015A (en)	1997-05-02	1999-10-05	Kobo Products S.A.R.L.	Stabilized liposomes
US6183762B1 (en)	1997-05-27	2001-02-06	Sembiosys Genetics Inc.	Oil body based personal care products
US6060070A (en)	1997-06-11	2000-05-09	Gorbach; Sherwood L.	Isoflavonoids for treatment and prevention of aging skin and wrinkles
FR2765106B1 (fr)	1997-06-27	2000-12-15	Dior Christian Parfums	Utilisation de tanins reticules en presence de proteines non reticulees avec les tanins comme agents cosmetiques pour ameliorer le lissage de la peau et/ou pour l'obtention d'un effet astringent
US5885596A (en)	1997-07-23	1999-03-23	Bristol-Myers Squibb Company	Methods and compositions for fine lines and/or wrinkles
US8039026B1 (en)	1997-07-28	2011-10-18	Johnson & Johnson Consumer Companies, Inc	Methods for treating skin pigmentation
DE19735587B4 (de)	1997-08-16	2012-03-22	Eberhard-Karls-Universität Tübingen Universitätsklinikum	Peptid mit radioprotektiver Wirkung, dieses enthaltende kosmetische oder pharmazeutische Zusammensetzung, für dieses kodierende Nukleinsäure, Herstellungsverfahren für dieses Peptid und die Verwendung als radioprotektives Agens
US6017893A (en)	1997-08-29	2000-01-25	Natures Sunshine Products, Inc.	Use of isoflavones to prevent hair loss and preserve the integrity of existing hair
WO1999015917A1 (fr)	1997-09-23	1999-04-01	Novartis Ag	Procede de traitement de surface d'hydrogel et article ainsi obtenu
US5972355A (en)	1997-09-30	1999-10-26	E-L Management Corp.	Stable compositions containing biologically active components
US6017549A (en)	1997-09-30	2000-01-25	E-L Management Corp.	Non-irritating cosmetic and pharmaceutical compositions
US5928658A (en)	1997-12-05	1999-07-27	U.S. Cosmetics	Oil-free wax-free solid cosmetic composition
EP1037653B1 (fr)	1997-12-16	2006-09-06	JOHNSON & JOHNSON CONSUMER COMPANIES, INC.	Compositions et procedes de regulation de la phagocytose et de l'expression de l'icam-1
FR2772613B1 (fr)	1997-12-19	2003-05-09	Oreal	Utilisation du phloroglucinol dans une composition cosmetique
US6030931A (en)	1998-02-03	2000-02-29	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Foaming cleansing skin product
DE19804376B4 (de)	1998-02-04	2004-09-16	Johnson & Johnson Gmbh	Lipidmischungen sowie deren Verwendung
US5928889A (en)	1998-02-13	1999-07-27	S.C. Johnson & Son, Inc.	Protocol for simulated natural biofilm formation
ATE259215T1 (de)	1998-03-16	2004-02-15	Procter & Gamble	Zusammensetzung zur regulierung des hauterscheinungsbildes
CA2323364A1 (fr)	1998-03-16	1999-09-23	The Procter & Gamble Company	Compositions pour modifier l'aspect exterieur de la peau
US5965153A (en)	1998-03-24	1999-10-12	Stabar Enterprises, Inc.	Dietary supplement for preventing or reducing shedding by animals
US6323219B1 (en) *	1998-04-02	2001-11-27	Ortho-Mcneil Pharmaceutical, Inc.	Methods for treating immunomediated inflammatory disorders
JP2002513948A (ja)	1998-05-05	2002-05-14	ボシュ・アンド・ロム・インコーポレイテッド	シリコーンヒドロゲルコンタクトレンズのプラズマ表面処理
US6087415A (en)	1998-06-11	2000-07-11	Johnson & Johnson Vision Care, Inc.	Biomedical devices with hydrophilic coatings
US6750229B2 (en) *	1998-07-06	2004-06-15	Johnson & Johnson Consumer Companies, Inc.	Methods for treating skin pigmentation
US8106094B2 (en) *	1998-07-06	2012-01-31	Johnson & Johnson Consumer Companies, Inc.	Compositions and methods for treating skin conditions
KR100577914B1 (ko)	1998-10-09	2006-05-10	가부시키가이샤 야쿠루트 혼샤	피부 외용제
US20020006418A1 (en)	1998-10-13	2002-01-17	John Kung	Composition to enhance permeation of topical skin agents
US6096327A (en)	1998-11-05	2000-08-01	Protease Sciences Inc.	Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
US6521237B2 (en)	1998-11-12	2003-02-18	Johnson & Johnson Consumer Companies, Inc.	Skin care composition
US20020197244A1 (en)	1998-12-07	2002-12-26	Miri Seiberg	Compositions and methods for regulating phagocytosis and ICAM-1 expression
CA2355894C (fr)	1999-01-19	2006-10-10	Pharmacia & Upjohn Company	Emballage a base de polyethylene sterilise par rayonnement gamma
AU3390400A (en)	1999-03-05	2000-09-21	Johns Hopkins University, The	Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7393548B2 (en)	1999-03-22	2008-07-01	J.P. M.E.D. Ltd.	Nano oil in glycerin emulsion
AU4647300A (en)	1999-04-19	2000-11-02	Procter & Gamble Company, The	Skin care compositions containing combination of skin care actives
US6444647B1 (en)	1999-04-19	2002-09-03	The Procter & Gamble Company	Skin care compositions containing combination of skin care actives
US6492326B1 (en)	1999-04-19	2002-12-10	The Procter & Gamble Company	Skin care compositions containing combination of skin care actives
MXPA01010631A (es)	1999-04-19	2002-03-14	Procter & Gamble	Composiciones para el cuidado de la piel que contienen una combinacion de ingredientes activos para el cuidado de la piel.
WO2000062741A2 (fr)	1999-04-19	2000-10-26	The Procter & Gamble Company	Compositions de soin pour la peau contenant une combinaison de principes actifs de soin pour la peau
US6447809B1 (en)	1999-05-11	2002-09-10	Metagenics, Inc.	Composition for promoting healthy bone structure
US6261603B1 (en)	1999-05-11	2001-07-17	Mcelwain Elizena A.	Skin cream
CA2373158A1 (fr)	1999-05-17	2000-11-23	The Procter & Gamble Company	Methodes de regulation de l'etat de tissus keratiniques chez un mammifere par l'application topique de compositions a base de phytosterol
AU5026700A (en)	1999-05-18	2000-12-05	Procter & Gamble Company, The	Methods for upregulating and/or modulating kgf production and increasing receptivity of keratinocytes to kgf
AU5026600A (en)	1999-05-18	2000-12-05	Procter & Gamble Company, The	Methods of regulating the condition of mammalian keratinous tissue
CA2373194A1 (fr)	1999-05-18	2000-11-23	The Procter & Gamble Company	Procede permettant de normaliser l'etat du tissu corne chez le mammifere
JP3661981B2 (ja)	1999-06-09	2005-06-22	株式会社ノエビア	制汗剤
DE19927229B4 (de) *	1999-06-10	2004-09-09	Coty B.V.	Enzymhaltiges Kosmetikum und dessen Verwendung
GB9913408D0 (en)	1999-06-10	1999-08-11	Albright & Wilson Uk Ltd	Personal care formulations
US6762158B2 (en)	1999-07-01	2004-07-13	Johnson & Johnson Consumer Companies, Inc.	Personal care compositions comprising liquid ester mixtures
US7985404B1 (en)	1999-07-27	2011-07-26	Johnson & Johnson Consumer Companies, Inc.	Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US6391288B1 (en)	1999-07-27	2002-05-21	Shiseido Co., Ltd.	Microcapsule and method of making the same
US7309688B2 (en)	2000-10-27	2007-12-18	Johnson & Johnson Consumer Companies	Topical anti-cancer compositions and methods of use thereof
MXPA01006891A (es)	1999-11-05	2002-04-24	Johnson & Johnson	Composiciones de soya para el cuidado y despigmentacion de la piel.
JP2003514001A (ja)	1999-11-16	2003-04-15	ユニリーバー・ナームローゼ・ベンノートシヤープ	ヒヨコマメ抽出物とレチノイドを含む美容組成物
FR2803747B1 (fr)	2000-01-18	2003-12-26	Pharmascience Lab	Utilisation d'isoflavones et/ou d'extraits de prunier d'afrique en pharmacie, cosmetique et en tant qu'additif alimentaire.
FR2807320B1 (fr)	2000-04-10	2002-05-24	Oreal	Utilisation de derives d'acide ascorbique pour augmenter la synthese des creramides epidermiques
US6433025B1 (en)	2000-04-13	2002-08-13	Cyanotech Corporation	Method for retarding and preventing sunburn by UV light
US6558656B2 (en)	2000-04-20	2003-05-06	Morris Mann	Oral and topical compositions and methods related thereto in the treatment of acne
FR2811226B1 (fr)	2000-06-05	2003-06-20	Clarins Laboratoires S A S	Composition cosmetique hydratante comprenant un inhibiteur de trypsine vegetal
US6432424B1 (en)	2000-06-29	2002-08-13	Johnson & Johnson Consumer Companies, Inc.	Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
ES2261446T3 (es)	2000-07-26	2006-11-16	Cognis France, S.A.S.	Utilizacion de una composicion que inhibe el crecimiento del pelo.
AU7730801A (en)	2000-09-29	2002-04-11	Johnson & Johnson Consumer Companies, Inc.	Composition to enhance permeation of tropical skin agents
US8431550B2 (en)	2000-10-27	2013-04-30	Johnson & Johnson Consumer Companies, Inc.	Topical anti-cancer compositions and methods of use thereof
DE60139151D1 (de)	2000-12-22	2009-08-13	Shiseido Co Ltd	Haarwuchshemmer und diese enthaltende zusammensetzungen
JP4169514B2 (ja)	2001-01-31	2008-10-22	松下電器産業株式会社	渦巻状電極群の製造方法および製造装置
WO2002067988A2 (fr)	2001-02-27	2002-09-06	The Regents Of The University Of Michigan	Utilisation d'inhibiteurs naturels de egfr permettant d'empecher les effets secondaires induits par un traitement par retinoides, des savons, et autres stimuli qui activent le recepteur du facteur de croissance epidermique
ES2337341T3 (es)	2001-02-28	2010-04-23	JOHNSON & JOHNSON CONSUMER COMPANIES, INC.	Composiciones que contienen productos de soja.
US20020160061A1 (en)	2001-02-28	2002-10-31	Claude Saliou	Use of legume products for the treatment of external aggressions
US7192615B2 (en)	2001-02-28	2007-03-20	J&J Consumer Companies, Inc.	Compositions containing legume products
US6555143B2 (en)	2001-02-28	2003-04-29	Johnson & Johnson Consumer Products, Inc.	Legume products
JP2004524335A (ja)	2001-03-16	2004-08-12	ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド	フィーバーフュー抽出物を含む組成物およびその使用方法
EP1455744A2 (fr)	2001-10-13	2004-09-15	Beiersdorf AG	Combinaison de principes actifs cosmetique et/ou dermatologique
EP1448157A1 (fr)	2001-11-09	2004-08-25	Beiersdorf AG	Preparation cosmetique et/ou dermatologique contenant de l'acide dicarboxylique d'octadecene et des substances filtrant les u.v.
US20030224075A1 (en)	2002-02-21	2003-12-04	Jue-Chen Liu	Soy composition for balancing combination skin
JP2004000019A (ja)	2002-03-27	2004-01-08	Ikeda Shokken Kk	変性防止剤および液体組成物
US20040063593A1 (en)	2002-09-30	2004-04-01	Wu Jeffrey M.	Compositions containing a cosmetically active organic acid and a legume product
US20050004561A1 (en) *	2003-07-01	2005-01-06	Lynn Halas	Method for removing hair
ATE342105T1 (de)	2003-08-26	2006-11-15	Johnson & Johnson Consumer Fr	Stabilisiertes antitranspirantmittel sojaprodukte enthaltend
AU2004290893A1 (en)	2003-10-29	2005-06-02	Johnson & Johnson Consumer France S.A.S.	Compositions comprising soy products and dioic acids
EP1543823A1 (fr)	2003-12-19	2005-06-22	Johnson & Johnson Consumer France SAS	Compositions cosmétiques contenant un extrait de gingko pour l'amélioration de la radiance de la peau

1998
- 1998-07-06 US US09/110,409 patent/US8039026B1/en not_active Expired - Fee Related
- 1998-07-23 ES ES98939062T patent/ES2215317T3/es not_active Expired - Lifetime
- 1998-07-23 PL PL98333284A patent/PL333284A1/xx unknown
- 1998-07-23 IL IL12909098A patent/IL129090A0/xx unknown
- 1998-07-23 EP EP98939062A patent/EP0948308B1/fr not_active Expired - Lifetime
- 1998-07-23 CN CN98801022.4A patent/CN1234735B/zh not_active Expired - Lifetime
- 1998-07-23 JP JP50978599A patent/JP4401441B2/ja not_active Expired - Fee Related
- 1998-07-23 AT AT98939062T patent/ATE260083T1/de active
- 1998-07-23 PT PT98939062T patent/PT948308E/pt unknown
- 1998-07-23 KR KR1019997002644A patent/KR100691395B1/ko not_active Expired - Fee Related
- 1998-07-23 AU AU87566/98A patent/AU8756698A/en not_active Abandoned
- 1998-07-23 DK DK98939062T patent/DK0948308T3/da active
- 1998-07-23 WO PCT/US1998/009799 patent/WO1999004752A2/fr active IP Right Grant
- 1998-07-23 ID IDW990134A patent/ID22061A/id unknown
- 1998-07-23 DE DE69821913T patent/DE69821913T2/de not_active Expired - Lifetime
- 1998-07-23 BR BR9806118-6A patent/BR9806118A/pt not_active Application Discontinuation
- 1998-07-23 BR BRPI9816322-1B1A patent/BR9816322B1/pt not_active IP Right Cessation
- 1998-07-23 HU HU0000216A patent/HUP0000216A3/hu unknown
- 1998-07-23 CA CA2267077A patent/CA2267077C/fr not_active Expired - Lifetime
- 1998-07-27 AR ARP980103691A patent/AR016780A1/es unknown
- 1998-09-04 TW TW087112280A patent/TW557216B/zh not_active IP Right Cessation
2007
- 2007-10-30 US US11/929,488 patent/US20080249029A1/en not_active Abandoned
2008
- 2008-11-04 JP JP2008283213A patent/JP2009114187A/ja active Pending
2011
- 2011-07-15 US US13/183,913 patent/US20120027706A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL333284A1 (en)	1999-11-22
ES2215317T3 (es)	2004-10-01
IL129090A0 (en)	2000-02-17
DE69821913T2 (de)	2004-12-23
JP2001502360A (ja)	2001-02-20
EP0948308A1 (fr)	1999-10-13
WO1999004752A3 (fr)	1999-05-14
JP2009114187A (ja)	2009-05-28
CN1234735B (zh)	2015-09-16
BR9806118A (pt)	1999-08-31
ATE260083T1 (de)	2004-03-15
CN1234735A (zh)	1999-11-10
US20120027706A1 (en)	2012-02-02
EP0948308B1 (fr)	2004-02-25
KR20000068645A (ko)	2000-11-25
TW557216B (en)	2003-10-11
US20080249029A1 (en)	2008-10-09
WO1999004752A9 (fr)	1999-04-08
ID22061A (id)	1999-08-26
WO1999004752A2 (fr)	1999-02-04
US8039026B1 (en)	2011-10-18
DK0948308T3 (da)	2004-06-14
PT948308E (pt)	2004-07-30
AR016780A1 (es)	2001-08-01
JP4401441B2 (ja)	2010-01-20
HUP0000216A3 (en)	2003-04-28
DE69821913D1 (de)	2004-04-01
BR9816322B1 (pt)	2014-07-15
CA2267077A1 (fr)	1999-02-04
HUP0000216A2 (hu)	2000-06-28
CA2267077C (fr)	2013-06-18
KR100691395B1 (ko)	2007-03-09

Publication	Publication Date	Title
EP0948308B1 (fr)	2004-02-25	Procede pour le traitement de la pigmentation de la peau
US6750229B2 (en)	2004-06-15	Methods for treating skin pigmentation
US6323219B1 (en)	2001-11-27	Methods for treating immunomediated inflammatory disorders
EP2640346B1 (fr)	2016-02-10	Compositions cosmétiques et méthodes pour inhiber ou réduire l'activité de la trypsine basées sur l' utilisation de cyclohexane-1,2,3,4,5,6-hexol et de n-acylaminoacide
MXPA01006891A (es)	2002-04-24	Composiciones de soya para el cuidado y despigmentacion de la piel.
AU2010249270B2 (en)	2012-04-12	Methods for treating skin pigmentation
MXPA99003054A (es)	2000-09-04	Metodos para tratar la pigmentacion de la piel
CZ104699A3 (cs)	2000-01-12	Způsob ovlivnění pigmentace kůže u savců a kompozice k provádění tohoto způsobu
HK1032543B (en)	2008-07-04	Methods for treating skin pigmentation

Legal Events

Date	Code	Title	Description
2003-01-16	MK5	Application lapsed section 142(2)(e) - patent request and compl. specification not accepted